# Oyster Point Pharma (stock symbol: OYST) Logo in transparent PNG and SVG formats

## Oyster Point Pharma Logo large

### Oyster Point Pharma Logo large Download PNG (45.57 KB)

![Oyster Point Pharma Logo large Download PNG (45.57 KB)](/img/orig/OYST_BIG-02b233a3.png)

### Oyster Point Pharma Logo large Download SVG (5.92 KB)

![Oyster Point Pharma Logo large Download SVG (5.92 KB)](/img/orig/OYST_BIG-c96da5a8.svg)

## Oyster Point Pharma Logo icon format

### Oyster Point Pharma Logo icon format Download PNG (78.12 KB)

![Oyster Point Pharma Logo icon format Download PNG (78.12 KB)](/img/orig/OYST-17ddf310.png)

### Oyster Point Pharma Logo icon format Download SVG (1.9 KB)

![Oyster Point Pharma Logo icon format Download SVG (1.9 KB)](/img/orig/OYST-47ff3143.svg)

## Oyster Point Pharma Logo large for dark backgrounds

### Oyster Point Pharma Logo large for dark backgrounds Download PNG (28.07 KB)

![Oyster Point Pharma Logo large for dark backgrounds Download PNG (28.07 KB)](/img/orig/OYST_BIG.D-ffdc05ac.png)

### Oyster Point Pharma Logo large for dark backgrounds Download SVG (5.87 KB)

![Oyster Point Pharma Logo large for dark backgrounds Download SVG (5.87 KB)](/img/orig/OYST_BIG.D-8229d867.svg)

## Oyster Point Pharma Logo icon format for dark backgrounds

### Oyster Point Pharma Logo icon format for dark backgrounds Download PNG (46.59 KB)

![Oyster Point Pharma Logo icon format for dark backgrounds Download PNG (46.59 KB)](/img/orig/OYST.D-acd133d9.png)

### Oyster Point Pharma Logo icon format for dark backgrounds Download SVG (1.85 KB)

![Oyster Point Pharma Logo icon format for dark backgrounds Download SVG (1.85 KB)](/img/orig/OYST.D-574a95b1.svg)

## About Oyster Point Pharma

Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry eye disease. It is also developing TYRVAYA that is in Phase II clinical trial for the treatment of for neurotrophic keratopathy. The company was incorporated in 2015 and is headquartered in Princeton, New Jersey.

1. Website domain: oysterpointrx.com
2. Employees: 303
3. Marketcap: $0.29 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
